vTv Therapeutics | 10-Q: Quarterly report
vTv Therapeutics | 8-K: vTv Therapeutics Announces 2024 First Quarter Financial Results and Provides Corporate Update
vTv Therapeutics | EFFECT: Others
vTv Therapeutics | 424B2: Prospectus
vTv Therapeutics | 424B2: Prospectus
vTv Therapeutics | CORRESP: CORRESP
vTv Therapeutics | DEF 14A: Definitive information statements
vTv Therapeutics | UPLOAD: Others
vTv Therapeutics | S-3: Registration statement for specified transactions by certain issuers
vTv Therapeutics | 8-K: Current report
vTv Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The ROP Revocable Trust dated 1/9/2018(50.3%),MacAndrews & Forbes Incorporated(47.8%), etc.
vTv Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Phillips Anne M.
vTv Therapeutics | 8-K: Current report
vTv Therapeutics | 10-K: Annual report
vTv Therapeutics | 8-K: vTv Therapeutics Announces 2023 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
vTv Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BAKER BROS. ADVISORS LP
vTv Therapeutics | 3: Initial statement of beneficial ownership of securities-Director BAKER BROS. ADVISORS LP
vTv Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Cheong Raymond
vTv Therapeutics | D: Filing D
vTv Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Samsara BioCapital, L.P.(10.4%),Samsara BioCapital GP, LLC(10.4%), etc.
No Data